-
Government consultation on voluntary carbon credit standards ‘to drive green investment’
VCMI’s Claims Code of Practice is one of the key standards recognised by the UK government
-
NYC comptroller warns fund managers to strengthen net-zero plans or lose their mandate
‘We won’t bow to pressure to move away from our commitments to decarbonisation’
-
Five sustainable equity funds that outperformed markets during ‘Liberation Day’ tariff chaos
Outperforming the MSCI All Countries World index
-
RLAM’s £11bn Sustainable fund range adopts SDR Focus label
The fund range is comprised of equity, fixed income and multi-asset funds
-
Mirova targets Europe’s 600 largest companies for biodiversity engagement campaign
Invited written responses to questions ahead of general meetings
-
Green Dream with J. Safra Sarasin’s Lurch: Preparing for future instability in sustainable investing
Balancing defensive and cyclical opportunities is key, says Daniel Lurch
-
Two-thirds of advice firms plan to invest more in AI
Biggest opportunities are in simplifying the advice process, enhancing compliance efforts and improving marketing and lead generation
-
Renewable energy adoption ‘limited’ in high-emission sectors
‘Powering the Earth differently is not enough. We must also build it to run differently.’
-
Earth Day 2025: Investment opportunity in ‘Our Power, Our Planet’
Three investment experts share their thoughts on what Earth Day means to them
-
Sustainable defence: Dilemma or oxymoron?
Ketan Patel explores where the red lines should not be crossed
-
Schroders publishes stewardship framework on climate risk resilience and adaptation
Previous research found the cost of extreme heat and flooding could equal more than 5% of operating profits
-
Q&A with Candriam’s Thomson: A science-led, transparent regulatory process is key for biotech sector
Cuts to US FDA funding are fuelling fears of delays to drug approvals that could kickstart a biotech stock selloff
